Altered expression of microRNA-16 has been observed in cancer, including malignancies of the breast, colon, brain , lung, lymphatic system, ovaries, pancreas , prostate and stomach. This difference in expression levels can be used distinguish between cancerous and healthy tissues and to determine clinical prognosis.
Modified expression of microRNA-16 has been noted in cancer, encompassing carcinomas of the breast, colon, brain, lung, lymphatic system, ovaries, pancreas, prostate, and stomach. The disparity in expression levels can be utilized to differentiate between malignant and healthy tissues and to forecast clinical outcomes.